PARP1 inhibitors: contemporary attempts at their use in anticancer therapy and future perspective

Current cancer therapies are based mainly on the use of compounds that cause DNA damage. Unfortunately, even the combination therapies do not give rewarding effects, due to the high efficiency of DNA damage repair mechanisms in tumor cells. Therefore, the present studies should be focused on protein...

Full description

Bibliographic Details
Main Authors: Ewelina Wiśnik, Marcin Ryksa, Maria Koter-Michalak
Format: Article
Language:English
Published: Index Copernicus International S.A. 2016-04-01
Series:Postępy Higieny i Medycyny Doświadczalnej
Subjects:
Online Access:http://phmd.pl/gicid/01.3001.0009.6809